Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Adam Stockmann"'
Autor:
Katarina Blagovic, Armon Sharei, Howard Bernstein, Katherine Seidl, Defne Yarar, Scott Loughhead, Emrah Ozay, Matthew Booty, David Soto, Olivia Pryor, Adam Stockmann, Disha Subramanya, Kelly Volk
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/cb105885adca49f0b52ad13cefdddb92
Autor:
Matthew G. Booty, Kelan A. Hlavaty, Adam Stockmann, Emrah Ilker Ozay, Carolyne Smith, Lina Tian, Edylle How, Disha Subramanya, Anita Venkitaraman, Christian Yee, Olivia Pryor, Kelly Volk, Katarina Blagovic, Ildefonso Vicente-Suarez, Defne Yarar, Melissa Myint, Amy Merino, Jonathan Chow, Tarek Abdeljawad, Harry An, Sophia Liu, Shirley Mao, Megan Heimann, LeeAnn Talarico, Miye K. Jacques, Eritza Chong, Lucas Pomerance, John T. Gonzalez, Ulrich H. von Andrian, Klavs F. Jensen, Robert Langer, Hendrik Knoetgen, Christine Trumpfheller, Pablo Umaña, Howard Bernstein, Armon Sharei, Scott M. Loughhead
Publikováno v:
The Journal of Immunology. 208:929-940
CD8+ T cell responses are the foundation of the recent clinical success of immunotherapy in oncologic indications. Although checkpoint inhibitors have enhanced the activity of existing CD8+ T cell responses, therapeutic approaches to generate Ag-spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::551c4a24375fe0d38f164f720ccd57bb
https://doi.org/10.4049/jimmunol.2100656
https://doi.org/10.4049/jimmunol.2100656
Autor:
Matthew G, Booty, Kelan A, Hlavaty, Adam, Stockmann, Emrah Ilker, Ozay, Carolyne, Smith, Lina, Tian, Edylle, How, Disha, Subramanya, Anita, Venkitaraman, Christian, Yee, Olivia, Pryor, Kelly, Volk, Katarina, Blagovic, Ildefonso, Vicente-Suarez, Defne, Yarar, Melissa, Myint, Amy, Merino, Jonathan, Chow, Tarek, Abdeljawad, Harry, An, Sophia, Liu, Shirley, Mao, Megan, Heimann, LeeAnn, Talarico, Miye K, Jacques, Eritza, Chong, Lucas, Pomerance, John T, Gonzalez, Ulrich H, von Andrian, Klavs F, Jensen, Robert, Langer, Hendrik, Knoetgen, Christine, Trumpfheller, Pablo, Umaña, Howard, Bernstein, Armon, Sharei, Scott M, Loughhead
Publikováno v:
J Immunol
CD8(+) T cell responses are the foundation of the recent clinical success of immunotherapy in oncologic indications. Although checkpoint inhibitors have enhanced the activity of existing CD8(+) T cell responses, therapeutic approaches to generate Ag-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::61c05f1e7053ee5957f5321dd8d2e325
https://pubmed.ncbi.nlm.nih.gov/35091434
https://pubmed.ncbi.nlm.nih.gov/35091434
Autor:
Katherine Seidl, Christian Klein, Adam Stockmann, Laura Codarri, Olivia Pryor, Christine Trumpfheller, Nicolini Valeria G, Matthew G. Booty, Pablo Umana, Armon Sharei, Melissa Myint, Scott Loughhead, Howard Bernstein
Publikováno v:
Regular and young investigator award abstracts.
Background We engineered unfractionated peripheral blood mononuclear cells (PBMCs) to function as antigen presenting cells (APCs) that generate potent CD8+ T cell responses. We investigated the combined efficacy of PBMC-based cancer vaccine with targ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3de87eb259b63a7f81aa62d14fbfd9b7
https://doi.org/10.1136/jitc-2020-sitc2020.0141
https://doi.org/10.1136/jitc-2020-sitc2020.0141
Autor:
Olivia Pryor, Matthew G. Booty, Kelly Volk, Armon Sharei, Defne Yarar, Scott Loughhead, Emrah Ilker Ozay, Adam Stockmann, Katherine Seidl, David Soto, Howard Bernstein, Blagovic Katarina, Disha Subramanya
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background The presentation of sufficient antigen on major histocompatibility complex class I (MHC-I) is essential to prime CD8+ T cells. Methods To achieve efficient MHC-I presentation, we used microfluidics cell squeezing (Cell Squeeze®) to delive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82bbd68cdcb6c451fa98a1c9b7532401
https://doi.org/10.1136/jitc-2020-sitc2020.0170
https://doi.org/10.1136/jitc-2020-sitc2020.0170
Autor:
Adam Stockmann, Wenping Song, Yves Sabbagh, Joseph Boulanger, Stephen J. O'Brien, Cynthia Arbeeny, Susan C. Schiavi
Publikováno v:
Journal of the American Society of Nephrology. 20:2348-2358
Intestinal phosphate absorption occurs through both a paracellular mechanism involving tight junctions and an active transcellular mechanism involving the type II sodium-dependent phosphate cotransporter NPT2b (SLC34a2). To define the contribution of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba2bb68496c4c074a18eb18988dd9e1f
https://doi.org/10.1681/asn.2009050559
https://doi.org/10.1681/asn.2009050559
Autor:
Chester A. Metcalf, Hongwei Wang, Adrian M. Senderowicz, Doug Lazarus, Christian G. Peters, Derek van der Poll, Tiffany Crowell, Lata Jayaraman, Adam Stockmann, Roy I. Case, Liang Zhao, Donna Brown, Scott Eliasof, Tiffany Halo, Ellen Rohde
Publikováno v:
Cancer Research. 77:PR10-PR10
Cerulean Pharma Inc.'s Dynamic Tumor Targeting™ Platform creates nanoparticle-drug conjugates (NDCs) designed to significantly mitigate a payload's limitations by providing sustained drug delivery to the tumor and superior therapeutic index through
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4e2b86184d23bc6bdb2d5fa4af33b3c
https://doi.org/10.1158/1538-7445.epso16-pr10
https://doi.org/10.1158/1538-7445.epso16-pr10
Autor:
Ellen Rohde, Adam Stockmann, Roy I. Case, Christian G. Peters, Ningning Zhang, Donna Brown, Lata Jayaraman, Douglas Lazarus, Scott Eliasof
Publikováno v:
Cancer Research. 76:1345-1345
CRLX101, an investigational nanoparticle-drug conjugate (NDC) containing the payload camptothecin, is currently being clinically evaluated in multiple treatment-refractory solid tumors. In preclinical models, CRLX101 is believed to release camptothec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbcd0fa8f118ddb3c33ebc5c56a7b164
https://doi.org/10.1158/1538-7445.am2016-1345
https://doi.org/10.1158/1538-7445.am2016-1345
Publikováno v:
Cancer Research. 76:3209-3209
CRLX101, an investigational nanoparticle-drug conjugate (NDC) containing the payload camptothecin, is currently being clinically evaluated in multiple treatment-refractory solid tumors. CRLX101 has been shown preclinically to be active in many differ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0aed33ea55eb0d7c74abb5d7a6550d0
https://doi.org/10.1158/1538-7445.am2016-3209
https://doi.org/10.1158/1538-7445.am2016-3209